Cardiopulmonary diseases with contributions of thrombosis, remodelling of pulmonary vessels and fibrosis. research hub

A Phase 1, open label, randomised, 2-period, 2 sequence, 7-days repeat-dosing, crossover oral pharmacokinetic trial comparing multiple dosing of CS014 to valproic acid in healthy adults.

This study is looking at a new medicine called CS014 for lung and heart problems that involve blood clots and changes in blood vessels. It compares how CS014 works in the body to a common medicine called valproic acid in healthy adults.